Literature DB >> 21696841

Epigenetics and diabetic cardiomyopathy.

Gurinder Bir Singh1, Rajni Sharma, Madhu Khullar.   

Abstract

Cardiovascular complications are a chief cause of mortality and morbidity in diabetic patients. Recent studies suggest that epigenetic changes which may arise as a consequence of environmental factors play an important role in predisposition to disease. Epigenetic mechanisms such as DNA methylation, chromatin remodeling and histone modifications regulate the gene expression in response to environmental signals. Role of epigenetics has been recognized in the pathology of diabetes, however its role in diabetic associated cardiomyopathy remains largely unexplored. In this article, we review current literature on the epigenetic mechanisms involved in diabetes and discuss recent evidence of epigenetic changes that may play an important role in pathophysiology of DCM.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21696841     DOI: 10.1016/j.diabres.2011.05.033

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Role of microRNAs in the pathogenesis of diabetic cardiomyopathy.

Authors:  Xinyu Liu; Shixue Liu
Journal:  Biomed Rep       Date:  2017-01-12

2.  Update on diabetic cardiomyopathy: inches forward, miles to go.

Authors:  Maggie N Tillquist; Thomas M Maddox
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

3.  DUSP-1 gene expression is not regulated by promoter methylation in diabetes-associated cardiac hypertrophy.

Authors:  Gurinder Bir Singh; Sanskriti Khanna; Satish K Raut; Saurabh Sharma; Rajni Sharma; Madhu Khullar
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-04-16

4.  MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy.

Authors:  Gurinder Bir Singh; Satish K Raut; Sanskriti Khanna; Akhilesh Kumar; Saurabh Sharma; Rishikesh Prasad; Madhu Khullar
Journal:  Mol Cell Biochem       Date:  2016-09-30       Impact factor: 3.396

5.  Cardiac overexpression of perilipin 2 induces atrial steatosis, connexin 43 remodeling, and atrial fibrillation in aged mice.

Authors:  Satsuki Sato; Jinya Suzuki; Masamichi Hirose; Mika Yamada; Yasuo Zenimaru; Takahiro Nakaya; Mai Ichikawa; Michiko Imagawa; Sadao Takahashi; Shoichiro Ikuyama; Tadashi Konoshita; Fredric B Kraemer; Tamotsu Ishizuka
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-10-29       Impact factor: 4.310

Review 6.  Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes.

Authors:  Jianxin Deng; Yunxiu Liao; Jianpin Liu; Wenjuan Liu; Dewen Yan
Journal:  Front Cell Dev Biol       Date:  2021-12-24

7.  Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunction.

Authors:  Yinliang Chen; Jinbao Yang; Ying Wang; Weike Shen; Jinlin Liu; Meng Yuan; Xiaoyu Hao; Li Zhong; Rui Guo
Journal:  Front Cardiovasc Med       Date:  2022-03-21

8.  Calcium sensing receptor protects high glucose-induced energy metabolism disorder via blocking gp78-ubiquitin proteasome pathway.

Authors:  Yuehong Wang; Ping Gao; Can Wei; Hongzhu Li; Li Zhang; Yajun Zhao; Bo Wu; Ye Tian; Weihua Zhang; Lingyun Wu; Rui Wang; Changqing Xu
Journal:  Cell Death Dis       Date:  2017-05-18       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.